Monomeric chemically modified allergens: Immunologic and physicochemical characterization

被引:49
作者
Mistrello, G [1 ]
Brenna, O [1 ]
Roncarolo, D [1 ]
Zanoni, D [1 ]
Gentili, M [1 ]
机构
[1] UNIV MOLISE,FAC AGR,DEPT STAAM,I-86100 CAMPOBASSO,ITALY
关键词
allergens; monomeric modified allergens; potassium cyanate; RAST inhibition;
D O I
10.1111/j.1398-9995.1996.tb04543.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Allergenic extracts (Der p, grass, and Parietaria) or single allergens such as Parj I (the major allergen of Parietaria) and ovalbumin (OA), a food allergen widely used in animal models, were chemically modified by reaction with potassium cyanate(KCNO), which transforms the epsilon-amino group of the lysine of proteinaceous allergens into ureido groups. KCNO-modified (carbamylated) allergens have low allergenic potency, as demonstrated in vitro (RAST inhibition) and in vivo (passive cutaneous anaphylaxis). When used to immunize rabbits, carbamylated allergens still induce IgG antibodies able to cross-react with native allergens (immunoblotting experiments). An interesting feature distinguishing carbamylated allergens from other chemically modified allergens is the preservation of the native monomeric dimension as demonstrated by SDS-PAGE analysis. Results are discussed from the perspective of clinical application of carbamylated allergens. (C) Munksgaard 1996.
引用
收藏
页码:8 / 15
页数:8
相关论文
共 33 条
[1]  
ANDERSON MC, 1981, RAST INHIBITION PROC
[2]   LOCAL NASAL IMMUNOTHERAPY IN ALLERGIC RHINITIS TO PARIETARIA - A DOUBLE-BLIND CONTROLLED-STUDY [J].
ANDRI, L ;
SENNA, GE ;
BETTELI, C ;
GIVANNI, S ;
ANDRI, G ;
FALAGIANI, P ;
LUGO, G .
ALLERGY, 1992, 47 (04) :318-323
[3]  
[Anonymous], 1938, US NAV M B
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   EFFECT OF CYANATE ON SEVERAL ANTI-HAPTEN ANTIBODIES - EVIDENCE FOR PRESENCE OF AN AMINO GROUP IN SITE OF ANTI-P-AZOBENZENEARSONATE ANTIBODY [J].
CHEN, CC ;
PRESSMAN, D ;
GROSSBERG, AL .
BIOCHEMISTRY, 1962, 1 (06) :1025-&
[6]  
DEMONCHY JGR, 1980, ALLERGOL IMMUNOPATH, V8, P281
[7]   IGG SUBCLASS ANTIBODY-RESPONSE IN GRASS POLLEN-ALLERGIC PATIENTS UNDERGOING SPECIFIC IMMUNOTHERAPY - PROGNOSTIC VALUE OF SERUM IGG SUBCLASS ANTIBODY-LEVELS EARLY IN IMMUNOTHERAPY [J].
DJURUP, R ;
OSTERBALLE, O .
ALLERGY, 1984, 39 (06) :433-441
[8]  
DURHAM SR, 1993, ALLERGY S16, V48, P15
[9]  
FALAGIANI P, 1990, Patent No. 908304124
[10]  
Fields R, 1972, Methods Enzymol, V25, P464, DOI 10.1016/S0076-6879(72)25042-X